(Q70039903)

English

Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry

scientific article published on 01 January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

based on heuristic

inferred from title

author name string

M C Malet-Martino

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

P Servin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J Bernadou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J P Armand

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R Martino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

273-279

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00175298

0 references

Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological manifestations in a phase 2 study of 13 patients treated with doxyfluridine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorour

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical study with 5'-deoxy-5-fluorouridine, a new fluoropyrimidine derivative

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxifluridine (5'-dFUrd) in patients with advanced colorectal carcinoma. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of doxifluridine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wernicke-Korsakoff-like syndrome in patients with colorectal carcinoma treated with high-dose doxifluridine (5'-dFUrd).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of doxifluridine in advanced colorectal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959633

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00175298

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2959633%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70039903&oldid=1766365226"